Characteristics of Patients Initiating Spiriva Respimat in Asthma in the UK: a Cross-sectional Study Based on the Clinical Practice Research Datalink
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2019
Price : $35 *
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 29 Oct 2019 Status changed from active, no longer recruiting to completed.
- 15 Oct 2019 Planned End Date changed from 30 Sep 2019 to 19 Oct 2019.
- 15 Oct 2019 Planned primary completion date changed from 30 Sep 2019 to 19 Oct 2019.